Drugs / Methohexital

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) BREVITAL SODIUM 1998-01-30 fda.gov
Approved US (FDA) BREVITAL SODIUM 1960-06-27 fda.gov

Trials 2 · a red edge is where a trial was stopped

1959196019611962196319641965196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 41 trial
Phase 4 NCT04187196 Apr 2020 → Sep 2022 atrial fibrillation, atrial flutter Wake Forest University Health Sciences Completed No outcome recorded
Phase not applicable1 trial
NCT01567852 Aug 2011 → Mar 2013 University of New Mexico Completed No outcome recorded
Also used as a comparator or background therapy in 8 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT04022226 Comparator Oct 2019 → Oct 2020 University of New Mexico Completed No outcome recorded
Phase 43 trials
Phase 4 NCT05655754 Comparator Nov 2022 → Oct 2025 overdue depressive disorder Medical University of Vienna Recruiting No outcome recorded
Phase 4 NCT01881763 Comparator Jun 2010 → Mar 2017 bipolar depression, major depressive disorder Northwell Health Completed No outcome recorded
Phase 4 NCT01907217 Background May 2008 → Nov 2013 depressive disorder St Patrick's Hospital, Ireland Completed No outcome recorded
Phase not applicable4 trials
NCT02624050 Comparator Aug 2016 → Jan 2018 hypotensive disorder Milton S. Hershey Medical Center Completed No outcome recorded
NCT02752724 Comparator Mar 2016 → Apr 2017 major depressive disorder VA Puget Sound Health Care System Completed No outcome recorded
NCT01367119 Comparator May 2011 → Mar 2012 depressive disorder Mayo Clinic Completed No outcome recorded
NCT01309581 Comparator Apr → Oct 2010 bipolar depression, major depressive disorder James Murrough Terminated No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 11 sources stand behind the page.

FieldValueCited text
Known as Methohexital ClinicalTrials.gov intervention name — accepted as the source's own label NCT02752724
8

NCT01881763

NCT01367119

NCT01567852

NCT01309581

NCT05655754

NCT02624050

NCT04187196

NCT04022226

Known as Brevimytal ChEMBL registry synonym — accepted as the source's own label CHEMBL7413
Known as Brevital sodium ChEMBL registry synonym — accepted as the source's own label CHEMBL7413
Known as Brietal sod ChEMBL registry synonym — accepted as the source's own label CHEMBL7413
Known as Methohexital civ ChEMBL registry synonym — accepted as the source's own label CHEMBL7413
Known as METHOHEXITAL SODIUM ChEMBL registry synonym — accepted as the source's own label CHEMBL7413
Known as Methohexital sodium salt ChEMBL registry synonym — accepted as the source's own label CHEMBL7413
Known as Methohexitone ClinicalTrials.gov intervention name — accepted as the source's own label NCT01907217
Known as Metohexital ChEMBL registry synonym — accepted as the source's own label CHEMBL7413
Known as Sodium methohexital ChEMBL registry synonym — accepted as the source's own label CHEMBL7413
Modality Small molecule CHEMBL7413
Route Intravenous “Methohexital 1 mg/kg IV as indicated for ECT” NCT01309581